FJ3.F Fujimori Kogyo Co. Ltd
- Market cap
- EUR 537M
- P/E
- 11.5x
- P/B
- 0.94x
- ROE
- 10.5%
- Dividend yield
- 3.15%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is FJ3.F undervalued?
Graham numberFJ3.F trades 30.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fujimori Kogyo Co. Ltd fundamental analysis
No fundamental analysis for Fujimori Kogyo Co. Ltd yet.
Fujimori Kogyo Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fujimori Kogyo Co. Ltd
ZACROS Corporation manufactures and sells products for wellness environmental solutions, information electronic, and industrial infrastructure in Japan and internationally. It operates through four segments: Wellness Business; Environmental Solutions Business; Information and Electronics Business; and Industrial Infrastructure Business. The company offers wellness products, including MediTect IV Bag, a non-adsorbing, low-leaching packaging for ready-to-use (RTU) drugs; BioPh…
Full company profileFujimori Kogyo Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fujimori Kogyo Co. Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 98.4B | 108B | 112B | 114B | 117B | 128B | 129B | 136B | 151B | 159B | 166B |
| Gross Profit | 21.1B | 23.7B | 23.9B | 24.9B | 26.7B | 28.7B | 25.7B | 29.7B | 34.7B | 36.8B | 39.5B |
| Operating Income | 6.87B | 8.58B | 8.13B | 8.86B | 10.3B | 10.3B | 5.88B | 8.34B | 10.1B | 11.1B | 13.4B |
| EBITDA | - | 13.2B | 13.2B | 13.0B | 15.6B | 16.6B | 13.0B | 13.2B | 15.8B | 18.7B | 16.9B |
| Net Income | 2.72B | 5.35B | 5.53B | 5.33B | 7.28B | 7.69B | 4.85B | 4.53B | 6.53B | 7.71B | 10.2B |
| EPS | 143 | 281 | 291 | 280 | 382 | 403 | 258 | 244 | 88 | 108 | 142 |
| Balance Sheet | |||||||||||
| Total Assets | 96.4B | 105B | 108B | 108B | 117B | 127B | 128B | 142B | 154B | 157B | 160B |
| Total Liabilities | 39.5B | 42.3B | 41.3B | 36.8B | 39.5B | 42.2B | 39.2B | 48.0B | 53.2B | 52.5B | 54.0B |
| Shareholders' Equity | 54.0B | 59.2B | 62.7B | 67.0B | 73.1B | 79.3B | 82.4B | 86.0B | 92.0B | 95.2B | 96.4B |
| Cash & Short-term Investments | 6.10B | 8.25B | 8.52B | 6.20B | 8.98B | 11.1B | 11.2B | 15.5B | 15.0B | 14.8B | 16.4B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.41B | 12.5B | 7.46B | 7.90B | 11.9B | 11.4B | 8.37B | 10.1B | 6.59B | 11.8B | - |
| Capital Expenditure | 4.32B | 3.23B | 5.23B | 6.71B | 9.61B | 5.12B | 5.13B | 6.94B | 18.1B | 21.8B | 0.00 |
| Free Cash Flow | - | 9.11B | 2.14B | 1.05B | 2.17B | 6.10B | 3.23B | 3.15B | -11.5B | -9.99B | - |
| Ratios | |||||||||||
| ROE | 5.0% | 9.0% | 8.8% | 8.0% | 10.0% | 9.7% | 5.9% | 5.3% | 7.1% | 8.1% | 10.5% |
| ROA | 2.8% | 5.1% | 5.1% | 4.9% | 6.2% | 6.0% | 3.8% | 3.2% | 4.2% | 4.9% | 6.4% |
| Net Profit Margin | 2.8% | 4.9% | 4.9% | 4.7% | 6.2% | 6.0% | 3.8% | 3.3% | 4.3% | 4.9% | 6.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Fujimori Kogyo Co. Ltd dividends
- Dividend yield
- 3.15%
- Forward dividend
- 0.23 EUR
- Payout ratio
- 33.0%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 2.55B | 36 | 33.0% |
| 2025 | JPY 1.95B | 26 | 29.9% |
| 2024 | JPY 1.58B | 85 | 34.9% |
| 2023 | JPY 1.60B | 85 | 33.0% |
| 2022 | JPY 1.52B | 80 | 19.8% |
| 2021 | JPY 1.33B | 70 | 18.3% |
| 2020 | EUR 1.29B | 68 | 24.3% |
| 2019 | EUR 1.26B | 66 | 22.7% |
| 2018 | EUR 1.26B | 66 | 23.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:1 on Sep 29, 2025.
Who owns Fujimori Kogyo Co. Ltd
- Insiders 21.33%
- Institutions 20.70%
- Public & others 57.96%
- Shares outstanding 71.6M
- Free float 53.4M
Fujimori Kogyo Co. Ltd company profile
- Company name
- Fujimori Kogyo Co. Ltd
- Ticker
- FJ3.F
- ISIN
- JP3821000001
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Cyclical
- Industry
- Containers & Packaging
- Employees
- 2,747
- Fiscal year end
- March
- Address
- Bunkyo Garden Gate Tower, Bunkyo, Japan, 112-0002
- Phone
- 81 3 5804 4221
- Website
- zacros.co.jp
About Fujimori Kogyo Co. Ltd
ZACROS Corporation manufactures and sells products for wellness environmental solutions, information electronic, and industrial infrastructure in Japan and internationally. It operates through four segments: Wellness Business; Environmental Solutions Business; Information and Electronics Business; and Industrial Infrastructure Business. The company offers wellness products, including MediTect IV Bag, a non-adsorbing, low-leaching packaging for ready-to-use (RTU) drugs; BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; and Total Thrombus-formation Analysis System, a flow chamber system. It also provides environmental solutions, such as flexible refill pouches; liquid containers; and high performance / high clean packaging. In addition, the company offers protective films; coating commissioned processing services; and free standing electrode, as well as adhesive films, release liners, tab seal film, and industrial laminate film. Further, it engages in industrial infrastructure activities. The company was formerly known as Fujimori Kogyo Co., Ltd. and changed its name to ZACROS Corporation in October 2024. ZACROS Corporation was founded in 1914 and is headquartered in Bunkyo, Japan.
Fujimori Kogyo Co. Ltd management
10- Mr. Taku ShimodaPresident & Representative Director · born 1972
- Mr. Michihiko SatoSVP, Head of Finance, HR, IT & Administration and Director · born 1964
- Mr. Kimihiko ShiomiSenior VP & Head of Supply Chain Management · born 1959
- Hiroshi SagaHead of Corporate Strategy & Planning · born 1959
- Atsushi TakematsuSenior Executive Officer & Head of Life Solutions Division Manager
- Kazuma EguchiVP, Senior Executive Officer & Head of Electronic Materials
- Toyoaki SuzukiExecutive Officer and Head of R&D
- Hitoshi HarasawaExecutive Officer & Head of Production Management
- Harutoshi IshizakaSenior Executive Officer & Head of Technical Development
- Tomoyuki SasakiExecutive Officer, Division Manager Medical Solutions & Head of Medical Solutions